Loading...
XTAE
NRGN
Market cap10mUSD
Dec 03, Last price  
270.50ILS
1D
-1.99%
1Q
-5.19%
IPO
-90.98%
Name

Nrgene Technologies Ltd

Chart & Performance

D1W1MN
XTAE:NRGN chart
P/E
P/S
8.43
EPS
Div Yield, %
Shrs. gr., 5y
7.49%
Rev. gr., 5y
-29.87%
Revenues
1m
-35.53%
7,313,0007,607,0007,035,0004,463,0003,159,0002,001,0001,290,000
Net income
-3m
L-35.93%
-4,494,000-3,911,000-3,146,000-8,338,000-6,207,000-5,243,000-3,359,000
CFO
-4m
L-8.80%
-839,000-3,578,000-1,423,000-5,567,000-6,118,000-3,908,000-3,564,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
IPO date
Jan 28, 2021
Employees
55
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT